Healthcare
Cathay Capital launches EUR 500m health fund
New vehicle will invest at the crossover of health care, life sciences and tech with EUR 5m-50m tickets
Sovereign Capital readies Nurse Plus for exit
Clearwater International hired to advise on sale of the UK-based healthcare staff agency
Advent raises USD 25bn for GPE X
Around 40% larger than its predecessor, the new fund was raised in less than six months, managing director Johanna Barr tells Unquote
PEAL Capital buys majority stake in Derma Medical
Deal marks the first investment by the female-led GP’s debut fund, which seeks to raise USD 300m
Sun European acquires DD Group in carve out from IDH
Vendor Palamon said deal is phase one of returning IDH to pureplay dentistry, will invest proceeds in M&A
Montagu launches Arkopharma sale; attracts PE and trade buyers
Bridgepoint and CVC’s Cooper among parties interested in the natural medicines and food supplements maker
BC Partners, Ardian among sponsors in second round of Simago sale
Antin and Eurazeo also in race for minority stake in the French medical imaging specialist
Ergon et al. sell Indo to PE-backed Rodenstock
Sherpa Capital and Oquendo Capital are also selling their stakes in the ophthalmic lenses producer
BC Partners, Cinven, Apax and Wendel circle Havea sale
French natural consumer healthcare manufacturer is set to collect non-binding bids next month
Portobello Structured Partnership holds EUR 250m final close
Vehicle is the GP's first dedicated fund for minority stakes in Southern European mid-market companies
Apollo buys minority stake in life sciences investor Sofinnova
Deal gives the French VC firm EUR 1bn in commitments for future funds as well as access to broader LP base
Andera Partners holds EUR 450m first close for Andera MidCap 5
Vehicle has a target of EUR 600m and is around 50% larger than its predecessor, Winch Capital 4
VC Profile: Jeito Capital in final stretch of biotech fund deployment
Founder Rafaèle Tordjman outlines the French sponsor’s strategy as it aims to remain independent amid wave of consolidation in healthcare funds
Montagu appoints advisers to sell ophthalmology group Artemis
Goldman Sachs and HSBC will run the auction for the German company, with launching expected after the summer
Ergon holds EUR 800m final close for Fund V
New EUR 800m fund is almost 40% larger than its EUR 580m, 2018-vintage predecessor
Permira exits Althea to F2i and DWS
Deal will see the Italian group broken into two, with DWS owning the UK arm and F2i the Italian assets
QPE backs MBO of Republic M!
The buyout of the British commercial services outsourcer is QPE's seventh platform deal under its maiden fund
LongeVC mulls 2023 fundraise for second fund
Biotech-focused VC could hit the road for new USD 180m-200m vehicle once Fund I’s hard-cap is reached
ArchiMed exits Eurolyser to trade for 6x return
The exit is the first for ArchiMed MED II fund, which post-deal will own ten other companies
Teachers' Venture Growth leads Alan's EUR 183m Series E
Temasek, Index, Coatue, Ribbit Capital, Exor, Dragoneer, and Lakestar also joined the round which values Alan at EUR 2.7bn
Lonsdale acquires Todays Dental
Sponsor plans to add-on over 40 dental practices in England and Wales; CEO managed add-ons for two of Europe's largest dental groups
Astorg beats sponsors to acquire CordenPharma
The sponsor competed with Advent International in the final round of an auction led by William Blair
Gilde Healthcare's RAD-X joins busy radiology pipeline
Lincoln to advise on the sale, which is expected to attract the interest of consolidators backed by infrastructure funds
LP Profile: Novo Ventures ready for steady deployment amid IPO lull
Danish biotech investor’s Naveed Siddiqi on opportunities arising from larger funding rounds and benefits of a two-pronged investment strategy
